Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Blood pressure monitoring to tackle kidney cancer?:

This article was originally published in Clinica

Executive Summary

Better monitoring of blood pressure could help stem the huge rise in kidney cancer, according to the findings of a report by Cancer Research UK. There has been a 68% rise in incidence of the disease over the last 20 years, the charity finds. While smoking is thought to account for some 30-40% of cases, obesity and high blood pressure are said to be the other main causes. Kidney cancer affects some 5,700 people annually in the UK, which is also said to have among the lowest survival rates for the disease in Europe.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT064850

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel